Table 1 Patient’s baseline characteristics at diagnosis of all patients
Characteristics | RDW(%) | P value | PLT(×109/L) | P value | HB(g/dL) | P value | |||
|---|---|---|---|---|---|---|---|---|---|
> 14.35(n = 93,%) | ≦14.35(n = 256,%) | > 126.5(n = 305,%) | ≦126.5(n = 44,%) | low(n = 187,%) | high(n = 162,%) | ||||
Age > 60 | 38(40.86) | 108(42.19) | 0.824 | 126(41.31) | 20(45.45) | 0.602 | 88(47.06) | 58(35.80) | 0.034 |
Gender (male) | 43(46.23) | 148(57.81) | 0.055 | 168(55.08) | 23(52.27) | 0.726 | 91(48.66) | 100(61.73) | 0.014 |
B symptoms (present) | 37(39.78) | 66(25.78) | 0.011 | 84(27.54) | 19(43.18) | 0.033 | 73(39.04) | 30(18.52) | < 0.001 |
Ann Arbor stage III/IV | 63(67.74) | 111(43.36) | < 0.001 | 143(46.89) | 31(70.45) | 0.003 | 117(62.57) | 57(35.19) | < 0.001 |
ECOG PS≧2 | 51(54.83) | 49(19.14) | < 0.001 | 75(24.59) | 16(36.36) | 0.096 | 75(40.11) | 16(9.88) | < 0.001 |
Serum LDH level≧246u/l | 58(62.37) | 88(34.38) | < 0.001 | 122(40.00) | 24(54.54) | 0.013 | 97(51.87) | 49(30.25) | < 0.001 |
Extranodal sites≧2 | 34(36.56) | 52(20.31) | 0.002 | 69(22.62) | 17(38.64) | 0.021 | 57(30.48) | 29(17.90) | 0.007 |
BM involvement | 9(9.68) | 6(2.34) | 0.007 | 11(3.61) | 4(9.09) | 0.201 | 11(5.88) | 4(2.47) | 0.192 |
IPI > 2 | 44(47.31) | 57(22.27) | < 0.001 | 83(27.21) | 18(40.91) | 0.061 | 74(39.57) | 27(16.67) | < 0.001 |